HWG Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-931
| Closed | -$202K | – | 45 |
|
|
2026
Q1 | $202K | Buy |
+931
| New | +$207K | 0.05% | 54 |
|
|
2025
Q2 | – | Sell |
-201
| Closed | -$42.1K | – | 55 |
|
|
2025
Q1 | $42.1K | Buy |
+201
| New | +$39.1K | 0.02% | 79 |
|
|
2024
Q4 | – | Sell |
-1,084
| Closed | -$214K | – | 51 |
|
|
2024
Q3 | $214K | Buy |
1,084
+23
| +2% | +$4.29K | 0.07% | 51 |
|
|
2024
Q2 | $182K | Buy |
+1,061
| New | +$176K | 0.07% | 39 |
|
|
2023
Q4 | $155K | Sell |
1,003
-9
| -0.9% | -$1.31K | 0.07% | 51 |
|
|
2023
Q3 | $151K | Buy |
1,012
+47
| +5% | +$6.9K | 0.08% | 51 |
|
|
2023
Q2 | $130K | Sell |
965
-144
| -13% | -$21.1K | 0.06% | 61 |
|
|
2023
Q1 | $177K | Sell |
1,109
-15,226
| -93% | -$2.33M | 0.1% | 49 |
|
|
2022
Q4 | $2.64M | Buy |
16,335
+1,823
| +13% | +$280K | 1.71% | 10 |
|
|
2022
Q3 | $1.95M | Buy |
+14,512
| New | +$2.08M | 1.39% | 12 |
|
|
2022
Q1 | $2.31M | Buy |
14,278
+7,979
| +127% | +$1.16M | 1.15% | 14 |
|
|
2021
Q4 | $853K | Buy |
+6,299
| New | +$744K | 0.37% | 46 |
|
|
2021
Q2 | $316K | Buy |
2,805
+420
| +18% | +$47.3K | 0.14% | 64 |
|
|
2021
Q1 | $258K | Sell |
2,385
-1,642
| -41% | -$176K | 0.13% | 51 |
|
|
2020
Q4 | $431K | Sell |
4,027
-287
| -7% | -$27.6K | 0.22% | 56 |
|
|
2020
Q3 | $378K | Sell |
4,314
-2,224
| -34% | -$209K | 0.34% | 50 |
|
|
2020
Q2 | $642K | Buy |
+6,538
| New | +$576K | 0.51% | 37 |
|
|
2019
Q3 | – | Sell |
-250
| Closed | -$18K | – | 116 |
|
|
2019
Q2 | $18K | Hold |
250
| – | – | 0.02% | 90 |
|
|
2019
Q1 | $20K | Hold |
250
| – | – | 0.02% | 54 |
|
|
2018
Q4 | $23K | Hold |
250
| – | – | 0.05% | 34 |
|
|
2018
Q3 | $24K | Hold |
250
| – | – | 0.02% | 66 |
|
|
2018
Q2 | $23K | Sell |
250
-9,854
| -98% | -$962K | 0.02% | 71 |
|
|
2018
Q1 | $956K | Buy |
10,104
+9,854
| +3,942% | +$1.08M | 0.89% | 30 |
|
|
2017
Q4 | $24K | Hold |
250
| – | – | 0.02% | 71 |
|
|
2017
Q3 | $22K | Hold |
250
| – | – | 0.02% | 66 |
|
|
2017
Q2 | $18K | Buy |
+250
| New | +$16.8K | 0.01% | 60 |
|
|
2015
Q3 | – | Sell |
-140,505
| Closed | -$9.44M | – | 3 |
|
|
2015
Q2 | $9.44M | Buy |
+140,505
| New | +$9.17M | 9.95% | 3 |
|
|
2014
Q4 | – | Sell |
-41,505
| Closed | -$2.4M | – | 31 |
|
|
2014
Q3 | $2.4M | Buy |
+41,505
| New | +$2.3M | 1.92% | 19 |
|
Other funds holding ABBV
ECSS
ATO
HWG Holdings's ABBV Position: Q2 2026 in Review
HWG Holdings sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 931 shares — an estimated $202K sold.
HWG Holdings first reported a position in ABBV in Q3 2014 and held it in 28 quarters. The position peaked at $9.44M in Q2 2015. 1,922 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- HWG Holdings reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
- HWG Holdings sold 931 AbbVie shares in Q2 2026, an estimated $202K.
- HWG Holdings first reported a position in AbbVie in Q3 2014 and held it in 28 quarters.
- HWG Holdings's AbbVie position peaked at $9.44M in Q2 2015.
- 1,922 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on HWG Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.